A metabolic basis for Alzheimer disease

Neurochemical Research

Volumn 28, Issue 10, 2003, Pages 1549-1552

  Perry, George ^a   Nunomura, Akihiko ^b   Raina, Arun K ^a   Aliev, Gjumrakch ^a   Siedlak, Sandra L ^a   Harris, Peggy L R ^a   Casadesus, Gemma ^a   Petersen, Robert B ^a   Bligh Glover, William ^a,c   Balraj, Elizabeth ^a,c   Petot, Grace J ^d   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c Cuyahoga County Coroner's Office   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Metabolism; Neuronal size; Nutrition; Oxidative stress; Vitamins

Indexed keywords

AGING; ALZHEIMER DISEASE; BRAIN METABOLISM; BRAIN NERVE CELL; CELL SIZE; METABOLIC RATE; NUTRITION; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; ANIMALS; CARBOHYDRATE METABOLISM; CELL SIZE; DIET; HUMANS; NEURONS;

EID: 0141705362     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025678510480     Document Type: Review

References (21)

1. Hardy, J. A. and Higgins, G. A. 1992. Alzheimer's disease: The amyloid cascade hypothesis. Science 256:184-185.
2. Hardy, J. and Selkoe, D. J. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297:353-356.
3. Selkoe, D. J. 2001. Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein: A reanalysis of a therapeutic hypothesis. J. Alzheimer's Dis. 3:75-81.
4. Trojanowski, J. O., Clark, C. M., Arai, H., Lee, V. M.-Y. 1999. Elevated levels of tau in cerebrospinal fluid: Implications for the antemortem diagnosis of Alzheimer's disease. J. Alzheimer's Dis. 1:297-305.
5. Perry, G., Castellani, R. J., Hirai, K., and Smith, M. A. 1998. Reactive oxygen species mediate cellular damage in Alzheimer disease. J. Alzheimer's Dis. 1:45-55.
6. Sheu, K. F., Cooper, A. J., Koike, K., Koike, M., Lindsay, J. G., and Blass, J. P. 1994. Abnormality of the α-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann. Neurol. 35:312-318.
7. Cardoso, S. M., Santos, S., Swerdlow, R. H., and Oliveira, C. R. 2001. Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB J. 15:1439-1441.
8. Small, G. W. 1996. Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease. J. Clin. Psychiatry 57(Suppl. 14):9-13.
9. Perry, G., Smith, M. A., McCann, C. E., Siedlak, S. L., Jones, P. K., and Friedland, R. P. 1998. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease. Brain Res. 791:63-66.
10. Kalaria, R. N., Gravina, S. A., Schmidley, I., Perry, G., and Harik, S. I. 1988. The glucose transporter of the human brain and blood-brain barrier. Ann. Neurol. 24:757-764.
11. Martins, R. 2001. Amyloid β precursor protein metabolism as a modulator of islet β-cell function. J. Alzheimer's Dis. 3:397-399.
12. Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., Van Bronswijk, W., and Martins, R. 2002. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J. Neurosci. 22:RC221.
13. Mark, R. J., Pang, Z., Geddes, J. W., Uchida, K., and Mattson, M. P. 1997. Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J. Neurosci. 17:1046-1054.
14. Uemura, E. and Greenlee, H. W. 2001. Amyloid beta-peptide inhibits neuronal glucose uptake by preventing exocytosis. Exp. Neurol. 170:270-276.
15. Figueroa, D. J., Shi, X.-P., Gardell, S. J., and Austin, C. P. 2001. AβPP secretases are co-expressed with AβPP in the pancreatic islets. J. Alzheimer's Dis. 3:393-396.
16. Smith, M. A., Petot, G. J., and Perry, G. 1999. Diet and oxidative stress: A novel synthesis of epidemiological data on Alzheimer's disease. J. Alzheimer's Dis. 1:203-206.
17. Tabet, N., Mantle, D., Walker, Z., and Orrell, M. 2002. Endogenous antioxidant activities in relation to concurrent vitamins A, C, and E intake in dementia. Int. Psychogeriatr. 14:7-15.
18. Grant, W. B. 1999. Dietary links to Alzheimer's disease. J. Alzheimer's Dis. 1:197-201.
19. Sparks, D. L., Martins, R., and Martin, T. 2002. Cholesterol and cognition: Rationale for the AD cholesterol-lowering treatment trial and sex-related differences in beta-amyloid accumulation in the brains of spontaneously hypercholesterolemic Watanabe rabbits. Ann. NY Acad. Sci. 977:356-366.
20. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C. S., Petersen, R. B., and Smith, M. A. 2001. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60:759-767.
21. Cash, A. D., Aliev, G., Siedlak, S. L., Fujioka, H., Vinters, H. V., Tabaton, M., Johnson, A. B., Paula-Barbosa, M., Avila, J., Jones, P. K., Castellani, R. J., Smith, M. A., and Perry, G. 2003. Microtubule reduction in Alzheimer disease and aging is independent of tau filament formation. Am. J. Pathol. in press.